RECRUITING Not applicable ClinicalTrials.gov

Post Exacerbation Asthma Clinic Telecare Intervention to Reduce Recurrent Exacerbations

Sponsor: Tel-Aviv Sourasky Medical Center • ClinicalTrials.gov ID: NCT07629830

Registry updated: 2026-09-24

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

Asthma exacerbations leading to emergency department visits or hospitalization are associated with a high risk of recurrent exacerbations, poor disease control, and increased healthcare utilization in the months following discharge. Early specialist follow-up during this vulnerable transition period remains limited, and many patients do not receive optimized long-term asthma management. The purpose of this study is to evaluate whether a structured remote asthma clinic intervention initiated shortly after hospital discharge can reduce recurrent exacerbations and improve asthma-related outcomes compared to standard community care. This prospective randomized study will enroll 220 adult patients (18-75 years) presenting to the emergency department at Tel Aviv Sourasky Medical Center with an asthma exacerbation. Participants will be randomly assigned to one of two groups: 1. Intervention group - will undergo two structured remote pulmonology follow-up visits via secure video consultation within 7-21 days and 5 months after discharge, including treatment optimization, inhaler technique assessment, and self-management education. 2. Control group - will continue standard community care without additional intervention. All participants will complete scheduled follow-up assessments over 12 months, including evaluation of exacerbations, asthma control, healthcare utilization, and medication use.

Interventions

Follow-up in a remote flare-up clinic (Other)
Participants assigned to the intervention group will undergo two structured remote pulmonology visits via secure video consultation, conducted 7-21 days and 5 months after discharge following an asthma exacerbation. The intervention will include assessment of asthma control and exacerbation history, inhaler technique evaluation, treatment optimization, and asthma self-management education according to current guidelines. Additional follow-up phone assessments will be conducted at 3, 9, and 12 months for study outcome evaluation only.

Eligibility criteria

Inclusion Criteria: * Presentation to the emergency department with an asthma exacerbation. * Ability to complete telephone follow-up and access to a personal e-mail account. * Agreement to participate in the study. * Written or verbal informed consent according to study group assignment. Exclusion Criteria: * Uncontrolled cardiac disease. * Any other uncontrolled medical condition. * Inability to complete telephone follow-up. * Pregnancy. * Patients lacking decision-making capacity.

Conditions

Asthma Acute Asthma Attack

Locations

Tel-Aviv Sourasky Medical Center, Tel Aviv — Tel Aviv, Israel

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment